Abstract

A 63yr retired serviceman with hypertension23 yrs, diabetic21 yrs, stroke 3yrs back had presented with Pseudophakic BCVA in RE CF@3m, N36 and LE CF@3m, N36 was under treatment for CNVM since 2019 had multiple injections of Biosimilar Ranibizumab since 2019. Both eyes also had panretinalphotocoagulation. Seeing some reactivation on followup he was advised for injection Brolicizumab in each eye.
2 months post-injection, his BCVA was BCVA in RE CF@3m, N18 and LE CF@3m, N18. But, in left eye funds revealed peripheral retinal hemorrhage in inferotemporal quadrant. He was advised to follow up after 2 months. When he reports with decreased in left eye with hand movement vision.He was diagnosed with vitreous hemorrhage in left eye for which he underwent vitrectomy with silicon oil. BCVA 10 days later was in left was CF @3m N18 with +3.50.Recently, silicon oil was removed and patient is doing good with restoration of his earlier visual acuity.He is on regular follow-up.